The Updated Nevada Medicaid Informational Bulletin on Medications and Services for Substance Use Disorders (SUD) serves as a vital guide for healthcare providers navigating the complexities of substance use treatment coverage across all six Nevada health care plans. This comprehensive resource details the transition to a Single Preferred Drug List (sPDL) as of January 1, 2026, and provides specific information on covered medications for opioid and alcohol dependence, including Prior Authorization (PA) requirements and Quantity Limits (QL). Beyond pharmacology, the bulletin outlines standards for Medication-Assisted Treatment (MAT) and residential care, specifying authorization windows for ASAM Residential Levels of Care unique to each plan. It also includes essential administrative guidelines on provider enrollment and eligibility verification, alongside links to the Medicaid Services Manual (MSM) and crisis intervention resources like 988 and Nevada 2-1-1, making it an indispensable tool for ensuring continuous, evidence-based care within the state.
